Claudio Lehmann Md - Irving, Texas 75038

Claudio Lehmann Md is categorized under Doctors in Irving, TX .

Business Name: Claudio Lehmann Md
Contact Person: Claudio Lehmann
Address: 5500 North Macarthur Boulevard, Irving, Texas 75038
Phone Number: (972) 518-1325
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Thin Center MD - Irving, TX 75038
M H Karjeker Md - Irving, TX 75038
Routledge Sherri DC - Irving, TX 75038
Pinnacle Anesthesia Consultant - Irving, TX 75038
Trinity Injury & Pain Center - Irving, TX 75038
B A P S Medical Services - Irving, TX 75038
Shin Edward T MD - Irving, TX 75038
Won Douglas S MD - Irving, TX 75038
Rodriguez Gabriel A MD - Irving, TX 75038
Raghu Vijayalaksh MD - Irving, TX 75038
Fritz Rodney R MD - Irving, TX 75038
Gross Leonard MD - Irving, TX 75038
Abramson Norton R MD - Irving, TX 75038
Feldman Cary S MD - Irving, TX 75038
Krenitsky Gabriel H MD - Irving, TX 75038
Magee Mitchell J MD - Irving, TX 75038
Sadana Neeti MD - Irving, TX 75038
Younis Basil A MD - Irving, TX 75038
Medbasics Inc - Irving, TX 75038
Prompt Care Internal Medicine Pa - Irving, TX 75038

The company Claudio Lehmann Md provides B2C services in the form of Doctors from its single location in Texas. 1 to 4 employees work for Claudio Lehmann Md, and the business now earns $100.000 to $499.999 per annum.

Claudio Lehmann Md was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Claudio Lehmann Md, please call Claudio Lehmann with the phone number (972) 518-1325 or visit its single location at 5500 North Macarthur Boulevard in Irving, Texas 75038.

The location of the single location can also be found using the coordinates 32.885485,-96.963885. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.